Science Board noms
This article was originally published in The Tan Sheet
Executive Summary
FDA requests nominations for membership on its Science Board, which advises the commissioner on technical issues, regulatory science and research agendas, according to a Sept. 5 Federal Register notice. Send nominations of individuals knowledgeable in the fields of food safety, nutrition, pharmacology, nanotechnology and other scientific disciplines to FDA at [email protected] by Oct. 6. In May, FDA Commissioner Andrew von Eschenbach said he intends to expand the board from 11 to 21 members and double its annual meetings from two to four in response to a board report pointing to the agency's deficiencies in expertise and technology (2"The Tan Sheet" June 30, 2008, p. 12)
You may also be interested in...
FDA Expects Greater Scientific Impact With Larger Advisory Board
FDA Commissioner Andrew von Eschenbach is attempting to increase the impact of the agency's Science Board Advisory Committee by doubling the number of members and meetings
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.